StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3080% below fair value
$0.71−0.04 (-5.15%)

Close on Nov 17, 2026Market cap $6.43MP/E –Yield –

Neuroone Medical Technologies revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Neuroone Medical Technologies's revenue for the twelve months ending Jun 30, 2026 was $9.47M, up 42.8% year over year. For fiscal 2025 it was $9.10M, up 163.5% from the year before. Over ten years it grew 110.2% a year on average. The highest annual figure on record is $9.10M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Sep 30, 2025$9.10M+163.5%
FY2024Sep 30, 2024$3.45M+76.9%
FY2023Sep 30, 2023$1.95M+1040.7%
FY2022Sep 30, 2022$171.17K-3.9%
FY2021Sep 30, 2021$178.15K–
FY2016Dec 31, 2016$0–
FY2015Dec 31, 2015$0-100.0%
FY2014Dec 31, 2014$773-38.1%
FY2013Dec 31, 2013$1.25K+35.6%
FY2012Dec 31, 2012$921-82.9%
FY2011Dec 31, 2011$5.40K+362.6%
FY2010Dec 31, 2010$1.17K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$1.97M+16.3%
Q2 FY2026CQ1 2026Mar 31, 2026$1.86M+34.3%
Q1 FY2026CQ4 2025Dec 31, 2025$2.89M-11.7%
Q4 FY2025CQ3 2025Sep 30, 2025$2.74M+906.6%
Q3 FY2025CQ2 2025Jun 30, 2025$1.70M+105.4%
Q2 FY2025CQ1 2025Mar 31, 2025$1.39M+0.7%
Q1 FY2025CQ4 2024Dec 31, 2024$3.27M+234.9%
Q4 FY2024CQ3 2024Sep 30, 2024$272.28K-63.3%
Q3 FY2024CQ2 2024Jun 30, 2024$825.78K+31.1%
Q2 FY2024CQ1 2024Mar 31, 2024$1.38M+195.4%
Q1 FY2024CQ4 2023Dec 31, 2023$977.65K+753.3%
Q4 FY2023CQ3 2023Sep 30, 2023$741.78K+978.4%
Q3 FY2023CQ2 2023Jun 30, 2023$629.91K+1865.4%
Q2 FY2023CQ1 2023Mar 31, 2023$466.18K+1174.3%
Q1 FY2023CQ4 2022Dec 31, 2022$114.58K+239.5%
Q4 FY2022CQ3 2022Sep 30, 2022$68.79K+42.3%
Q3 FY2022CQ2 2022Jun 30, 2022$32.05K-20.1%
Q2 FY2022CQ1 2022Mar 31, 2022$36.58K+100.6%
Q1 FY2022CQ4 2021Dec 31, 2021$33.75K-52.8%
Q4 FY2021CQ3 2021Sep 30, 2021$48.34K–
Q3 FY2021CQ2 2021Jun 30, 2021$40.10K–
Q2 FY2021CQ1 2021Mar 31, 2021$18.24K–
Q1 FY2021CQ4 2020Dec 31, 2020$71.47K–
Q2 FY2017CQ2 2017Jun 30, 2017$0–
Q1 FY2017CQ1 2017Mar 31, 2017$0–
Q4 FY2016CQ4 2016Dec 31, 2016$0–
Q3 FY2016CQ3 2016Sep 30, 2016$0–
Q2 FY2016CQ2 2016Jun 30, 2016$0–
Q1 FY2016CQ1 2016Mar 31, 2016$0-100.0%
Q4 FY2015CQ4 2015Dec 31, 2015$0-100.0%
Q3 FY2015CQ3 2015Sep 30, 2015$0–
Q2 FY2015CQ2 2015Jun 30, 2015$0–
Q1 FY2015CQ1 2015Mar 31, 2015$113–
Q4 FY2014CQ4 2014Dec 31, 2014$166–

More Neuroone Medical Technologies figures

See a number that looks wrong?